Brief: Illumina Partners Go Beyond The Genome, Driving Cancer Breakthroughs
25/02/2026 14:16
Feb 25 (Reuters) - Illumina Inc ILMN.O: ILLUMINA PARTNERS GO BEYOND THE GENOME, DRIVING CANCER BREAKTHROUGHS USING SPATIAL TRANSCRIPTOMICS, EPIGENOMICS, AND PROTEOMICS Source text: ID:nPn2FVblDa Further company coverage: ILMN.O (((( Reuters.briefs@thomsonreuters.com ;));))
Recent news on Illumina
See all newsBrief: Illumina Bioinsight Platform Expands With New Software To Accelerate The Path From Sequencing To Discovery
US RESEARCH ROUNDUP-Analog Devices, IBM, Qualcomm
Brief: Illumina - Establishes Unsecured Commercial Paper Program On October 8, 2026
Brief: Illumina To Announce Third Quarter 2026 Financial Results
Brief: Illumina Releases Spliceai2 To Help Advance Rare Disease Research